Katherine E. Jacobitz
View detailed information about Katherine E. Jacobitz, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Pharmaceutical Quality Operations IV. Took part in 12 inspections of 12 companies, 2016–2026.
Inspections (12)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| June 17, 2026 | Jubilant HollisterStier LLC | Not classified | Drug Quality Assurance | #1303204 |
| February 18, 2026 | Gilead Sciences, Inc. | VAI | Drug Quality Assurance | #1304734 |
| September 26, 2025 | Making Cosmetics Inc | Not classified | #1285802 | |
| September 4, 2025 | Sparsha Pharma Usa Inc | VAI | Drug Quality Assurance | #1280450 |
| August 1, 2025 | Surmasis Pharmaceutical, LLC | VAI | Drug Quality Assurance | #1277270 |
| October 25, 2024 | Bachem Americas, Inc. | Not classified | #1255253 | |
| December 15, 2017 | Charles River Laboratories Germany GmbH | VAI | Drug Quality Assurance | #1035009 |
| April 6, 2017 | Ajinomoto Althea, Inc. | VAI | Drug Quality Assurance | #1024252 |
| February 3, 2017 | Adhexpharma | NAI | Compliance: Devices | #1008978 |
| January 27, 2017 | Biolab, S.L. | Not classified | #1002851 | |
| January 24, 2017 | GP Pharm SA | VAI | Compliance: Devices | #1004446 |
| December 15, 2016 | Life Technologies Corporation | Not classified | #1000889 |
Documents (21)
- WARNING LETTER · Calvin Scott & Company, Inc. · March 12, 2020
- WARNING LETTER · Customceutical Compounding · March 8, 2019
- WARNING LETTER · Foothills Professional Pharmacy, LTD · October 24, 2018
- UNTITLED LETTER · Lifetime Value Pharmacy III Inc. · September 22, 2020
- UNTITLED LETTER · Palisades Compounding Pharmacy
- WARNING LETTER · Colonial Dames Company, Ltd · April 12, 2023
- EIR · Unimed Pharmaceuticals, Inc. · February 14, 2023
- WARNING LETTER · Conversio Health · September 25, 2019
- STATE REFERRAL LETTER · JD & SN Inc. · July 5, 2017
- WARNING LETTER · First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · June 14, 2019
- STATE REFERRAL LETTER · Unknown Company · July 5, 2017
- 483 · Sparsha Pharma Usa Inc · September 4, 2025
- 483 · Making Cosmetics Inc · September 26, 2025
- 483 · Surmasis Pharmaceutical, LLC · August 1, 2025
- 483 · Abbott Vascular Inc · November 15, 2007
- 483 · Ajinomoto Althea, Inc. · April 6, 2017
- 483 · Ajinomoto Althea, Inc. · February 10, 2012
- 483 · Gilead Sciences, Inc. · February 18, 2026
- 483 · Jubilant HollisterStier LLC · June 17, 2026
- EIR · Johnson & Johnson Consumer Inc · October 8, 2015
- 483 · Roche Singapore Technical Operations Pte. Ltd. · August 1, 2022
Frequently inspected with (10)
Related Office
Person Information
Name
Katherine E. Jacobitz
Title
Director of Investigations Branch
Role
Regulatory Personnel
ID: 9a713b44-95c4-43a2-83bb-8d30062d8345
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.